| http://www.w3.org/ns/prov#value | - PHARMAC needs to work closely with [the minister], the Ministry of Health, and other key stakeholders to advance the medical devices, hospital pharmaceuticals and vaccines policy work flowing on from recent Cabinet decisions. [The minister] particularly expects PHARMAC to work closely with Health Benefits Limited and clinicians to manage transition risks and ensure the smooth progression of the me
|
